Back

Real-world effectiveness of inclisiran in patients receiving intensive lipid-lowering therapy

24 April 2026 (08:30 - 18:00)
Organised by: Logo
Congress Presentation Part of: Poster session (2) Drug therapy EAPC Premium Access ESC Preventive Cardiology 2026 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Doctor Guillermo Villar Ochoa

UNIVERSITY HOSPITAL VIRGEN DE VALME, Seville (Spain)

84 More presentations in this session

Presentation thumbnail
Prediction models for valvular heart disease in the community: a systematic review and meta-analysis
Mr W. Ginks (Leeds, GB)
Abstract Slides
Presentation thumbnail
The prevalence and clinical significance of ecg abnormalities in individuals with a bicuspid aortic valve
Doctor E. Nakou (London, GB)
Abstract Slides
Presentation thumbnail
Arrhythmogenic cardiomyopathy. Prospects for assessing the degree of electrical instability in the damage zone
Professor S. Bondarev (Padua, IT)
Abstract
Presentation thumbnail
Age-stratified predictors of ventricular ectopy in non-ischemic DCM
Mrs N. Hart-Foia (Cluj Napoca, RO)
Abstract Slides
Presentation thumbnail
Cardiopulmonary fitness in patients with a systemic right ventricle: the QUALISYSTEMIC study
Doctor M. Audie (Bordeaux, FR)
Abstract Slides

Access the full session

Session thumbnail
Poster session (2)

The Event

Event poster

ESC Preventive Cardiology 2026

24 April 2026 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Efficacy and safety of inclisiran in reducing LDL cholesterol and triglycerides: real-life experience in a third level hospital: a descriptive, bivariate, and multivariate analysis.
4 April 2025
thumbnail
Congress Presentation
Real-world use of rosuvastatin 40 mg and ezetimibe 10 mg after ACS: is this combination effective in achieving guideline-recommended LDL-C goals after discharge?
20 March 2026
thumbnail
Webinar
New trial evidence in the field of lipid management
19 April 2024
thumbnail
Congress Presentation
Effects of PCSK9 inhibitor on adverse limb outcomes in patients with critical limb ischemia
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources